Ivosidenib
Brand name: Tibsovo
Ivosidenib comes in 2 pill versions in our database, in 1 strength, from 2 manufacturers. Check the imprint to tell them apart.
Ivosidenib pill images
250 mg 2 pills
What is Ivosidenib used for?
Ivosidenib is used for acute myeloid leukemia.
- Medicine type
- Isocitrate dehydrogenase 1 inhibitor
Official uses from the US prescribing label
Newly Diagnosed Acute Myeloid Leukemia
TIBSOVO is indicated in combination with azacitidine or as monotherapy for the treatment of newly diagnosed acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.
Relapsed or Refractory Acute Myeloid Leukemia
TIBSOVO is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test.
Relapsed or Refractory Myelodysplastic Syndromes
TIBSOVO is indicated for the treatment of adult patients with relapsed or refractory myelodysplastic syndromes (MDS) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test.
Locally Advanced or Metastatic Cholangiocarcinoma
TIBSOVO is indicated for the treatment of adult patients with previously treated, locally advanced or metastatic cholangiocarcinoma with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test.
From the FDA-approved label on DailyMed (published Dec 22, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.